Raymond James & Associates’s Addus HomeCare ADUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-2,340
Closed -$233K – 3875
2022
Q4
$233K Buy
+2,340
New +$245K ﹤0.01% 3365
2021
Q2
– Sell
-5,626
Closed -$588K – 4084
2021
Q1
$588K Buy
5,626
+839
+18% +$95.6K ﹤0.01% 2895
2020
Q4
$561K Buy
4,787
+295
+7% +$30.4K ﹤0.01% 2728
2020
Q3
$425K Sell
4,492
-1,589
-26% -$149K ﹤0.01% 2748
2020
Q2
$563K Buy
6,081
+1,691
+39% +$146K ﹤0.01% 2509
2020
Q1
$297K Buy
+4,390
New +$380K ﹤0.01% 2782
2019
Q4
– Sell
-5,956
Closed -$472K – 3661
2019
Q3
$472K Buy
+5,956
New +$482K ﹤0.01% 2691

Other funds holding ADUS

Raymond James & Associates's ADUS Position: Q1 2023 in Review

Raymond James & Associates sold out of Addus HomeCare (ADUS) in Q1 2023, closing a stake of 2,340 shares — an estimated $233K sold.

Raymond James & Associates first reported a position in ADUS in Q3 2019 and held it in 7 quarters. The position peaked at $588K in Q1 2021. 233 funds tracked by Wall St. Rank hold ADUS as of Q1 2023.

  • Raymond James & Associates reported no remaining Addus HomeCare position as of Q1 2023 after selling out during the quarter.
  • Raymond James & Associates sold 2,340 Addus HomeCare shares in Q1 2023, an estimated $233K.
  • Raymond James & Associates first reported a position in Addus HomeCare in Q3 2019 and held it in 7 quarters.
  • Raymond James & Associates's Addus HomeCare position peaked at $588K in Q1 2021.
  • 233 funds tracked by Wall St. Rank held Addus HomeCare as of Q1 2023.

Based on Raymond James & Associates's 13F filing for Q1 2023, filed 14 Apr 2023.